Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

HIV-infection in Russia Alexander Panteleev Head of the HIV/TB department City TB Hospital # 2, St-Petersburg, Russia.
Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence.
Experiences with Compulsory Drug Detention in Thailand: Evidence from the Mitsampan Community Research Project Kanna Hayashi Lianping Ti Karyn Kaplan Paisan.
HIV in British Columbia: Recent Trends Presentation for the Pacific AIDS Network February 25, 2009 Stephen Smith Manager, Blood-borne Pathogens.
Washington D.C., USA, July 2012www.aids2012.org Access to HCV treatment for people with HIV/HCV Professor Gregory Dore Viral Hepatitis Clinical Research.
Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:
Role of Routine HIV Testing in Concentrated Epidemics Operations Research for Optimizing the HIV Testing Program in an Urban Canadian Setting K Vasarhelyi,
The Impact of Police Violence on HIV Risks among People Who Inject Drugs in Thailand Kanna Hayashi 1, 2 Lianping Ti 1 Karyn Kaplan 3 Paisan Suwannawong.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Page 1 Use of modest financial incentives to improve engagement of drug users in HIV testing and post- test follow-up: results of a randomized controlled.
High uptake of mobile HIV testing in Bangkok Metropolitan Area, Thailand Objective To promote pro-active strategy of HIV Counseling and Testing (HCT) by.
The effects of OAT and HAART on the cause-specific risk of mortality among HIV positive people who inject drugs Bohdan Nosyk, PhD Associate Professor,
Conditional Cash Transfers and Contingency Management Strategies in Substance Users Mark Hull MD, MHSc, FRCPC Clinical Assistant Professor, University.
Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,
Concepts in Infectious Disease Epidemiology: Models & Prediction David Vlahov, Ph. D.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,
From Research to Practice: HIV/AIDS in Thailand Thira Sirisanthana, MD Chiang Mai University.
1 Dose-response relationship between incarceration and non- adherence to HAART among injection drug users in a Canadian setting M-J Milloy 1,2, T Kerr.
Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.
Thailand is located at the Golden Triangle: Population: 65 millions Current Status of Drug Use and HIV in Thailand Apinun Aramrattana, MD, PhD Faculty.
Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept.
Slide 1 of 42 IAS–USA AU EDITED FINAL: Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,
IAS-NIDA RESEARCH FELLOWSHIP Encouraging HIV and Drug Use Research ANNOUNCEMENT OF 2010 FELLOWS Nora Volkow & Julio Montaner 23 July 2010.
Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.
1 st International Treatment as Prevention (TasP) Workshop Overview British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, DSc(hon), FRCPC,
Research and Advocacy to Ensure Health and HIV Services for HIV-positive Women in Chiang Mai Women's Prison Wednesday, July 21 Paisan Suwannawong, Thai.
British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, FRCPC, FCCP, FRSC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health.
Phylodynamically Estimated HIV Diversification Rates Reveal Prevention of HIV-1 by Antiretroviral Therapy Jeffrey B. Joy, Richard H. Liang, Rosemary M.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
SAFE PLACES GAME. With safe injection sites would there be an increased use of addiction treatment? The SIF's opening was associated independently with.
Colleen Daniels Stop TB Department World Health Organisation TB, HIV and Drug Use The overview.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
High Rates of HIV/AIDS within Aboriginal Communities, the Red Road and other initiatives to address these needs By. Nava K.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Longitudinal Study of Bone Mineral Density and Vitamin D Levels Among Perinatally HIV-infected.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Tuberculosis and HIV-AIDS: Achievements with ARV access Dr. Humberto Costa, MD Minister of Health, Brazil.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
An ethical analysis contrasting international HIV/AIDS relief efforts with relief efforts for other diseases and disasters BC Centre for Excellence In.
Thai AIDS Treatment Action Group (TTAG)
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Vancouver, British Columbia, Canada
XIVV International AIDS Conference, Mexico City 3-8 August 2008
Volume 355, Issue 9221, Pages (June 2000)
DEPARTMENT OF PAEDIATRICS, THE QUEEN ELIZABETH HOSPITAL,
HIV testing guidance: know, treat, prevent
Global epidemiology of injecting drug use
Background Results (continued) Methods Results Discussion
Pacific Cannabis Pacific Cannabis - pacificcannabis.ca What excellent quality products, but at minimum prices? You are on.
Managing Women Living With HIV Infection
Engagement in methadone maintenance therapy associated with less time with plasma HIV-1 RNA viral load above 1500 copies/mL among a cohort of HIV-positive.
Hepatitis C in the HIV-infected patient
Projected new adult infections and total adult deaths in sub-Saharan Africa, in millions, by the year 2020: Impact of three scenarios compared to baseline.
Volume 379, Issue 9811, Pages (January 2012)
The HIV Epidemic among People who Inject Drugs
Amsterdam, Netherlands 26 July 2018
Correlates of Opioid and Benzodiazepine Co-Prescription Among People Living with HIV in British Columbia, Canada Stephanie Parent1, Seonaid Nolan2,3, Nadia.
Precise capture of thoracic morbidity and mortality: Essential to the process and culture of quality improvement  Anna L. McGuire, MD, MSc, FRCSC, John.
HIV Viral Suppression Rate in U. S
Cumulative number of HIV infections
AIDS 2018 | Abstract No. TUPDC0102 | Tuesday July 24, 2018
The parameters in the Reference Group model fit by EPP
Receipt of medication-assisted treatment halves the risk of HIV-1 RNA viral load rebound for HIV-positive women who use illicit drugs Joëlla W. Adams,
Attitudes, Confidence and Knowledge towards Antiretroviral Pre-Exposure Prophylaxis (PrEP) Prescription among Healthcare Providers in Thailand Poster:
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan Suwannawong 3 Evan Wood 1,4 Julio Montaner 1,4 Thomas Kerr 1,4 1 British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada 2 Interdisciplinary Graduate Studies Program, University of British Columbia, Vancouver, BC, Canada 3 Thai AIDS Treatment Action Group, Bangkok, Thailand 4 Department of Medicine, University of British Columbia, Vancouver, BC, Canada

Page 2 HIV EPIDEMIC IN THAILAND Source: MOPH Thailand

Page 3 HIV TESTING Reduce HIV-related morbidity and mortality May minimize high-risk behaviour Provide linkages to HIV treatment and care services Wood et al. (2006). Impact of HIV testing on uptake of HIV therapy among antiretroviral naïve HIV-infected injection drug users. Drug and Alcohol Review, 25,

Page 4 BARRIERS TO HIV TESTING IN THAILAND Uptake of HIV testing <20% among IDU in Asia-Pacific 2003 “War on Drugs” campaign Fear of HIV-positive test result Stigma and discrimination Breaches of patient confidentiality

Page 5 OBJECTIVES Seek – Test – Treat - Retain Explore acceptability of novel methods of testing and counselling (VCT)

Page 6 MITSAMPAN COMMUNITY RESEARCH PROJECT A collaborative research effort involving: Peer researchers involved in all stages of the project Former/active drug users trained as peer researchers  Interviewers  Outreach workers Three completed cycles to date (2008, 2009, 2011)

Page 7 MITSAMPAN HARM REDUCTION CENTER (MSHRC) Photo by Rico Gustav

Page 8 METHODS Recruited IDU through peer outreach and word-of-mouth Completed interviewer-administered questionnaire Eligibility criteria:  Injection drug use in the previous six months  Reside in Bangkok or adjacent provinces  Informed consent Data collected in 2011 Restricted sample to HIV-negative IDU or IDU of unknown HIV serostatus

Page 9 RESULTS

Page 10 RESULTS Willingness to receive peer- delivered pre-test counselling Multivariate associations AOR (95%CI) Binge use* 2.39 (1.46 – 3.95) Higher than secondary level education 1.98 (1.25 – 3.16) Male gender 0.52 (0.29 – 0.90) Willingness to receive peer- delivered rapid HIV testing Multivariate associations AOR (95%CI) Binge use* 2.23 (1.36 – 3.70) Higher than secondary level education 2.06 (1.27 – 3.39) Ever incarcerated 2.68 (1.56 – 4.72) Avoid HIV tests 0.24 (0.10 – 0.52) Ever been to MSHRC 1.63 (1.02 – 2.62) Willingness to receive peer- delivered post-test counselling Multivariate associations AOR (95%CI) Binge use* 2.40 (1.48 – 3.93) Ever incarcerated 1.94 (1.16 – 3.33) Avoid HIV tests 0.23 (0.09 – 0.52) AOR: adjusted odds ratio, CI: confidence interval, MSHRC: Mitsampan Harm Reduction Center *Activities in the previous six months

Page 11 RESULTS Willingness to receive peer- delivered pre-test counselling Multivariate associations AOR (95%CI) Binge use* 2.39 (1.46 – 3.95) Higher than secondary level education 1.98 (1.25 – 3.16) Male gender 0.52 (0.29 – 0.90) Willingness to receive peer- delivered rapid HIV testing Multivariate associations AOR (95%CI) Binge use* 2.23 (1.36 – 3.70) Higher than secondary level education 2.06 (1.27 – 3.39) Ever incarcerated 2.68 (1.56 – 4.72) Avoid HIV tests 0.24 (0.10 – 0.52) Ever been to MSHRC 1.63 (1.02 – 2.62) Willingness to receive peer- delivered post-test counselling Multivariate associations AOR (95%CI) Binge use* 2.40 (1.48 – 3.93) Ever incarcerated 1.94 (1.16 – 3.33) Avoid HIV tests 0.23 (0.09 – 0.52) AOR: adjusted odds ratio, CI: confidence interval, MSHRC: Mitsampan Harm Reduction Center *Activities in the previous six months

Page 12 DISCUSSION Substantial proportion willing to get peer-delivered VCT at a drug user-run drop-in centre Peer-delivered VCT could reach key groups who may be missed through traditional public health methods  IDU who were previously incarcerated  IDU engaged in high intensity drug use Need for HIV prevention education efforts for IDU  Increase awareness of HIV risks and transmission  Target IDU with lower education and those who avoid HIV tests

Page 13 CONCLUSION Current HIV testing approaches in Thailand are limited Need for ongoing HIV prevention education efforts Potential of novel approaches to VCT for IDU Photo by BC-CfE

Page 14 ACKNOWLEDGEMENTS MSCRP participants MSHRC, TTAG, & O-Zone House staff and volunteers Chulalongkorn University: Dr. Niyada Kitaying-Angsulee BC-CfE staff: Tricia Collingham, Deborah Graham, Caitlin Johnston, Calvin Lai, Peter Vann MSCRP staff: Prempreeda Pramoj Na Ayutthaya, Arphatsaporn Chaimongkon, Sattara Hattirat

Page 15